The Future of AI-powered Clinical Trials
Examining AI's Current and
Future Impact on Clinical Trials
Tuesday | November 11, 2025 | 11 AM ET
Join our exclusive live webinar for an extraordinary discussion on:
- The New Data Source Ecosystem: Continuous, Real-World Data Collection and Analyses
- The Regulatory Landscape: The Changing Regulatory Environment for Adapting to AI
- Ethical and Patient-Centric AI: Consent Aspects and Context for Predictions
- Conclusion & Q&A
Can't make it to the webinar?
No worries. Be sure to register, and we'll send you a recording of the live session.
Your data will be kept and managed in Binah.ai systems in accordance with our Privacy Policy.
Join our live webinar to hear from industry experts about The Future of AI-powered Clinical Trials. This high-level discussion offers a look at how AI is transforming clinical research, exploring continuous, real-world data collection. We will then delve into the Regulatory Landscape, addressing the changing environment and essential updates to regional guidances for successful AI adaptation and compliance. Finally, the session will tackle Ethical and Patient-Centric AI, covering complex consent aspects and the crucial need for context and transparency in AI predictions. Don't miss this essential briefing on navigating the next era of clinical discovery.
Revolutionize Clinical Trials with
35 Seconds
AI-Powered Video Screening
Easy to Use
No hardware or learning curve
High Quality
Clinically validated
Saves Costs and Time
Software-based, scales effortlessly
Inclusive
Supports all genders and Fitzpatrick scale skin tones.
No Privacy Concerns
Safeguards end-user data
Easy to Integrate
Available as SDK or end-to-end application platform
Empower Clinical Trials with Remote, Video-based
Health Data Monitoring
Access lab-grade insights across key cardiovascular indicators, vital signs, stress levels, and blood biomarkers to dramatically reduces the time and manual effort traditionally required for data entry and aggregation. Ensure consistency and integrity across datasets, and make clinical trial results more robust and reliable.

Our Panel
Len Rosenberg, PhD, RPh
Scientific Advisory Board
Binah.ai
Dr. Rosenberg is a 35 plus year executive with proven experience in driving operational excellence at all levels within the pharmaceutical, biotechnology, eclinical and contract research organization sectors. With his diverse background which includes executive management, clinical and regulatory operations, business development, eclinical technology solutions and new product/licensing evaluations, he brings tremendous hands on insights to optimizing the drug development cycle, from the early start-up stage to global product registration. Dr. Rosenberg is Head, Clinical Operations at Beat AML, LLC, a division of The Leukemia & Lymphoma Society and also Managing Partner of eP2Consulting, Inc. since 2001. Dr. Rosenberg received his Ph.D., from the Kellogg Pharmaceutical Clinical Scientist Program, University of Minnesota, College of Pharmacy and his Bachelor of Science, Pharmacy, from the Philadelphia College of Pharmacy and Science.
David Evans
President and CEO
Research Data Corporation
Dave Evans is recognized industry-wide as a leading technology visionary for developing and implementing complex process and system solutions and as an expert in the areas of information standards, regulatory compliance and quality governance. He was the architect and developer of the first electronic drug submission to the FDA in 1985 and has been responsible for more than 100 electronic regulatory submissions and complex clinical data warehouse systems. He brings over 40 years’ experience to the industry, serving in various executive-level positions in software development, clinical research, regulatory and healthcare industries. Most recently, he was the President & CEO of CDISC. Prior to that, he was the Global Head of Quality Governance and Regulatory Compliance for Accenture Life Sciences, the CIO of Octagon Research Solutions and co-founder of Premier Research and Research Data Corporation. He has also served on the CDISC Board of Directors and has been an active member of many other industry advisory board, organizations and initiatives. Dave received his MS in Biomedical Engineering from Drexel University and his BS in Biology from Ursinus College.
David Maman
Co-Founder and CEO
Binah.ai
David spearheads the team in fulfilling Binah.ai’s vision and mission. David is a serial entrepreneur who has taken numerous start-ups from vision to international success. Binah.ai is David’s 13th start-up where he sets the strategy and manage the execution of the company's mission to enable wellness and healthcare services to everyone, everywhere.
Technology You Can Trust
.png)

Binah.ai's Market Acclaimed Technology